Comparing maternal substance use and perinatal outcomes before and during the COVID-19 pandemic.
J Perinatol
; 43(5): 664-669, 2023 05.
Article
in English
| MEDLINE | ID: covidwho-2232529
ABSTRACT
OBJECTIVE:
To examine the effect of the COVID-19 pandemic on maternal substance abuse and neonatal outcomes. STUDYDESIGN:
Cross-sectional observational study of neonates admitted to the NICU and born to mothers with evidence of substance abuse pre-pandemic compared to during the COVID-19 pandemic.RESULT:
We noted a significant increase in fentanyl (12% vs. 0.6%, p < 0.001) and tobacco use (64% vs. 33%, p < 0.001) during the pandemic compared to pre-pandemic, including an increase in fentanyl use among mothers enrolled in opioid maintenance therapy (OMT) during the pandemic (32.3% vs. 1.5%, p < 0.001). There was a significant increase in preterm births (58% vs. 48%, p = 0.022) and lower birth weight (2315 ± 815 vs. 2455 ± 861 g, p = 0.049) during pandemic.CONCLUSION:
There was a significant increase in maternal fentanyl use during the pandemic, even with OMT enrollment, with an increase in preterm births and lower birth weights among infants born to mothers with substance use.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Substance-Related Disorders
/
Premature Birth
/
COVID-19
Type of study:
Observational study
/
Prognostic study
/
Randomized controlled trials
Limits:
Female
/
Humans
/
Infant
/
Infant, Newborn
/
Pregnancy
Language:
English
Journal:
J Perinatol
Journal subject:
Perinatology
Year:
2023
Document Type:
Article
Affiliation country:
S41372-023-01613-8
Similar
MEDLINE
...
LILACS
LIS